• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five Forces Summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product o RIDTs for influenza A - Market size and forecast 2019-2024 o RIDTs for influenza B - Market size and forecast 2019-2024 o Market opportunity by Product • Market Segmentation by End-user o Market segments o Comparison by End user o Hospitals and diagnostic laboratories - Market size and forecast 2019-2024 o Academic and research centers - Market size and forecast 2019-2024 o Homecare - Market size and forecast 2019-2024 o Market opportunity by End user • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography o Volume drivers – Demand led growth o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o bioMérieux SA o Bio-Rad Laboratories Inc. o Danaher Corp. o F. Hoffmann-La Roche Ltd. o Hologic Inc. o Quidel Corp. o Siemens Healthineers AG o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Key Finding 9 • 9: Parent market • 10: Market characteristics • 11: Offerings of vendors included in the market definition • 12: Market segments • 13: Global - Market size and forecast 2019 - 2024 ($ billion) • 14: Global market: Year-over-year growth 2019 - 2024 (%) • 15: Five forces analysis 2019 & 2024 • 16: Bargaining power of buyers • 17: Bargaining power of suppliers • 18: Threat of new entrants • 19: Threat of substitutes • 20: Threat of rivalry • 21: Market condition - Five forces 2019 • 22: Product - Market share 2019-2024 (%) • 23: Comparison by Product • 24: RIDTs for influenza A - Market size and forecast 2019-2024 ($ billion) • 25: RIDTs for influenza A - Year-over-year growth 2019-2024 (%) • 26: RIDTs for influenza B - Market size and forecast 2019-2024 ($ billion) • 27: RIDTs for influenza B - Year-over-year growth 2019-2024 (%) • 28: Market opportunity by Product • 29: End user - Market share 2019-2024 (%) • 30: Comparison by End user • 31: Hospitals and diagnostic laboratories - Market size and forecast 2019-2024 ($ billion) • 32: Hospitals and diagnostic laboratories - Year-over-year growth 2019-2024 (%) • 33: Academic and research centers - Market size and forecast 2019-2024 ($ billion) • 34: Academic and research centers - Year-over-year growth 2019-2024 (%) • 35: Homecare - Market size and forecast 2019-2024 ($ billion) • 36: Homecare - Year-over-year growth 2019-2024 (%) • 37: Market opportunity by End user • 38: Customer landscape • 39: Market share by geography 2019-2024 (%) • 40: Geographic comparison • 41: North America - Market size and forecast 2019-2024 ($ billion) • 42: North America - Year-over-year growth 2019-2024 (%) • 43: Europe - Market size and forecast 2019-2024 ($ billion) • 44: Europe - Year-over-year growth 2019-2024 (%) • 45: Asia - Market size and forecast 2019-2024 ($ billion) • 46: Asia - Year-over-year growth 2019-2024 (%) • 47: ROW - Market size and forecast 2019-2024 ($ billion) • 48: ROW - Year-over-year growth 2019-2024 (%) • 49: Key leading countries • 50: Market opportunity by geography ($ billion) • 51: Impact of drivers and challenges • 52: Vendor landscape • 53: Landscape disruption • 54: Industry risks • 55: Vendors covered • 56: Market positioning of vendors • 57: Abbott Laboratories - Overview • 58: Abbott Laboratories - Business segments • 59: Abbott Laboratories - Key offerings • 60: Abbott Laboratories - Key customers • 61: Abbott Laboratories - Segment focus • 62: Becton, Dickinson and Co. - Overview • 63: Becton, Dickinson and Co. - Business segments • 64: Becton, Dickinson and Co. - Key offerings • 65: Becton, Dickinson and Co. - Key customers • 66: Becton, Dickinson and Co. - Segment focus • 67: bioMérieux SA - Overview • 68: bioMérieux SA - Business segments • 69: bioMérieux SA - Key offerings • 70: bioMérieux SA - Key customers • 71: bioMérieux SA - Segment focus • 72: Bio-Rad Laboratories Inc. - Overview • 73: Bio-Rad Laboratories Inc. - Business segments • 74: Bio-Rad Laboratories Inc. - Key offerings • 75: Bio-Rad Laboratories Inc. - Key customers • 76: Bio-Rad Laboratories Inc. - Segment focus • 77: Danaher Corp. - Overview • 78: Danaher Corp. - Business segments • 79: Danaher Corp. - Key offerings • 80: Danaher Corp. - Key customers • 81: Danaher Corp. - Segment focus • 82: F. Hoffmann-La Roche Ltd. - Overview • 83: F. Hoffmann-La Roche Ltd. - Business segments • 84: F. Hoffmann-La Roche Ltd. - Key offerings • 85: F. Hoffmann-La Roche Ltd. - Key customers • 86: F. Hoffmann-La Roche Ltd. - Segment focus • 87: Hologic Inc. - Overview • 88: Hologic Inc. - Business segments • 89: Hologic Inc. - Key offerings • 90: Hologic Inc. - Key customers • 91: Hologic Inc. - Segment focus • 92: Quidel Corp. - Overview • 93: Quidel Corp. - Business segments • 94: Quidel Corp. - Key offerings • 95: Quidel Corp. - Key customers • 96: Quidel Corp. - Segment focus • 97: Siemens Healthineers AG - Overview • 98: Siemens Healthineers AG - Business segments • 99: Siemens Healthineers AG - Key offerings • 100: Siemens Healthineers AG - Key customers • 101: Siemens Healthineers AG - Segment focus • 102: Thermo Fisher Scientific Inc. - Overview • 103: Thermo Fisher Scientific Inc. - Business segments • 104: Thermo Fisher Scientific Inc. - Key offerings • 105: Thermo Fisher Scientific Inc. - Key customers • 106: Thermo Fisher Scientific Inc. - Segment focus • 107: Currency conversion rates for US$ • 108: Research Methodology • 109: Validation techniques employed for market sizing • 110: Information sources • 111: List of abbreviations

Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Quidel Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc.